Basel Medical Group Stock Performance

BMGL Stock   0.61  0.01  1.67%   
The firm shows a Beta (market volatility) of 1.39, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Basel Medical will likely underperform. At this point, Basel Medical Group has a negative expected return of -0.7%. Please make sure to confirm Basel Medical's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Basel Medical Group performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Basel Medical Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
1
Can Basel Medical Group Ltd stock maintain growth trajectory - Weekly Profit Recap Weekly Watchlist of Top Performers - newser.com
11/19/2025
2
Receipt of Delinquency Notification from Nasdaq
12/01/2025
3
Basel Medical Group receives delinquency notification from Nasdaq - MSN
12/05/2025
4
Basel Medical Group Ltd Short Interest Update
01/20/2026
5
Basel Medical receives delinquency notification from Nasdaq
01/23/2026
6
12 Health Care Stocks Moving In Fridays Intraday Session - Benzinga
01/30/2026

Basel Medical Relative Risk vs. Return Landscape

If you would invest  112.00  in Basel Medical Group on November 15, 2025 and sell it today you would lose (51.00) from holding Basel Medical Group or give up 45.54% of portfolio value over 90 days. Basel Medical Group is currently does not generate positive expected returns and assumes 7.9374% risk (volatility on return distribution) over the 90 days horizon. In different words, 71% of stocks are less volatile than Basel, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Basel Medical is expected to under-perform the market. In addition to that, the company is 10.22 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.

Basel Medical Target Price Odds to finish over Current Price

The tendency of Basel Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.61 90 days 0.61 
about 83.19
Based on a normal probability distribution, the odds of Basel Medical to move above the current price in 90 days from now is about 83.19 (This Basel Medical Group probability density function shows the probability of Basel Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.39 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Basel Medical will likely underperform. Additionally Basel Medical Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Basel Medical Price Density   
       Price  

Predictive Modules for Basel Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Basel Medical Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.030.618.59
Details
Intrinsic
Valuation
LowRealHigh
0.030.628.60
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Basel Medical. Your research has to be compared to or analyzed against Basel Medical's peers to derive any actionable benefits. When done correctly, Basel Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Basel Medical Group.

Basel Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Basel Medical is not an exception. The market had few large corrections towards the Basel Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Basel Medical Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Basel Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.08
β
Beta against Dow Jones1.39
σ
Overall volatility
0.26
Ir
Information ratio -0.14

Basel Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Basel Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Basel Medical Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Basel Medical Group generated a negative expected return over the last 90 days
Basel Medical Group has high historical volatility and very poor performance
Basel Medical Group has some characteristics of a very speculative penny stock
Basel Medical Group has high likelihood to experience some financial distress in the next 2 years
Basel Medical Group has a poor financial position based on the latest SEC disclosures
About 54.0% of the company shares are held by company insiders
Latest headline from news.google.com: 12 Health Care Stocks Moving In Fridays Intraday Session - Benzinga

Basel Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Basel Stock often depends not only on the future outlook of the current and potential Basel Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Basel Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding18.8 M
Cash And Short Term InvestmentsM

Basel Medical Fundamentals Growth

Basel Stock prices reflect investors' perceptions of the future prospects and financial health of Basel Medical, and Basel Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Basel Stock performance.

About Basel Medical Performance

By examining Basel Medical's fundamental ratios, stakeholders can obtain critical insights into Basel Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Basel Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 48.93  51.38 
Return On Tangible Assets(0.82)(0.78)
Return On Capital Employed(0.41)(0.39)
Return On Assets(0.82)(0.78)
Return On Equity(2.86)(2.72)

Things to note about Basel Medical Group performance evaluation

Checking the ongoing alerts about Basel Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Basel Medical Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Basel Medical Group generated a negative expected return over the last 90 days
Basel Medical Group has high historical volatility and very poor performance
Basel Medical Group has some characteristics of a very speculative penny stock
Basel Medical Group has high likelihood to experience some financial distress in the next 2 years
Basel Medical Group has a poor financial position based on the latest SEC disclosures
About 54.0% of the company shares are held by company insiders
Latest headline from news.google.com: 12 Health Care Stocks Moving In Fridays Intraday Session - Benzinga
Evaluating Basel Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Basel Medical's stock performance include:
  • Analyzing Basel Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Basel Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Basel Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Basel Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Basel Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Basel Medical's stock. These opinions can provide insight into Basel Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Basel Medical's stock performance is not an exact science, and many factors can impact Basel Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Basel Medical Group is a strong investment it is important to analyze Basel Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Basel Medical's future performance. For an informed investment choice regarding Basel Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Basel Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. Projected growth potential of Basel fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Basel Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.51)
Revenue Per Share
0.644
Quarterly Revenue Growth
0.322
Return On Assets
(0.05)
Return On Equity
(1.95)
Investors evaluate Basel Medical Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Basel Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Basel Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Basel Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Basel Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Basel Medical's market price signifies the transaction level at which participants voluntarily complete trades.